Carpal Tunnel Syndrome. Carpal tunnel syndrome
Conditions
Interventions
Intervention 1: Intervention group: Combined conventional physical therapy including wrist splints, electrical stimulation, phonophoresis, and wrist manual therapy and neck manual therapies. Intervent
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Tingling, numbness, burning or pain in at least 2 of digits 1, 2 or 3 Ages 18-60 years Positive Phalen sign or Tinnel sign over the carpal tunnel or carpal compression test CTS symptoms present for greater than twelve weeks Pain intensity at least a 4/10 on a Visual Analog Scale scale over the past 24 h Electrodiagnostic findings indicate mild to moderate damage to the median nerve
Exclusion criteria
Exclusion criteria: Any sensory or motor deficit in either the ulnar or radial nerve History of surgery or injection in the wrist area Presence of systemic diseases such as rheumatoid arthritis, fibromyalgia A history of systemic disease associated with carpal tunnel syndrome (such as diabetes mellitus or hyperthyroidism or hypothyroidism) The presence of conditions that might cause numbness in the hand, including cervical radiculopathy, cervical ribs, plexopathy, and polyneuropathy Pregnancy History of neck, shoulder or upper extremity trauma
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: One day before first session of treatment, two or three days after end of treatment. Method of measurement: Visual Analog Scale.;Upper limb level of function. Timepoint: One day before first session of treatment, two or three days after end of treatment. Method of measurement: Disabilities of the arm, shoulder and hand (DASH) questionnaire.;Symptoms and functional status of patients. Timepoint: One day before first session of treatment, two or three days after end of treatment. Method of measurement: Boston Carpal Tunnel(BCTQ) Questionnaire.;Median sensory nerve conduction velocity. Timepoint: One day before first session of treatment, two or three days after end of treatment. Method of measurement: Tru trace 4 EMG system DEYMED electromyography device.;Median nerve motor distal latency. Timepoint: One day before first session of treatment, two or three days after end of treatment. Method of measurement: Tru trace 4 EMG system DEYMED electromyography device. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZarrin Milad
Ahvaz University of Medical Sciences
Outcome results
None listed